AUG 19, 2026 · PHASE 1 TRIAL
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
ClinicalTrials.gov
Phase 1 interventional study of a beta-3 agonist in polycystic ovary syndrome with planned physiological endpoints; no results posted in this registry record.
Reported
Planned enrollment100
Study phasePhase 1
Primary outcome measure (Cohorts…Change in BAT metabolic activity at 4 weeks